Stroke Dx
Culver City, US · Founded 2022 · 8 employees on LinkedIn · 3 known investors
Find your way into Stroke Dx
Sign up to see every warm intro you have to Stroke Dx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stroke Dx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuraNova (formerly StrokeDx) develops non-invasive neurovascular diagnostic technology aimed at rapid detection for stroke and brain-related conditions. Its product is not yet FDA cleared or commercially available.
Founders & leadership
Stroke Dx was founded in 2022 by Alexander Ballatori and Shane Shahrestani.

Investors · 3
How we know: DigiTx Partners LLC's portfolio page · funding news · medtechinnovator.org · the VCSheet dataset · Not right? Tell us
How we know: FREEFLOW's portfolio page · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 rounds · 2022–2024
▶$4.3MraisedJun 2024 · 3 investors · Other Health CareRule 506(b)
- Kevin BarrettDirector
- Alexander BallatoriExecutive Officer, Director
- Shane ShahrestaniExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.3M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.7MraisedOct 2022 · 5 investors · Other Health CareRule 506(b)
- Alexander BallatoriExecutive Officer, Director
- Shane ShahrestaniExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Stroke Dx do?
- NeuraNova (formerly StrokeDx) develops non-invasive neurovascular diagnostic technology aimed at rapid detection for stroke and brain-related conditions. Its product is not yet FDA cleared or commercially available.
- Who founded Stroke Dx?
- Stroke Dx was founded by Alexander Ballatori, Shane Shahrestani in 2022.
- Who are Stroke Dx's investors?
- Stroke Dx's investors include DigiTx Partners LLC, FREEFLOW.
- How much funding has Stroke Dx raised?
- Stroke Dx has disclosed $6M raised across 2 rounds.
- Where is Stroke Dx headquartered?
- Stroke Dx is headquartered in Culver City, US.

